Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C472791 |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in decreased expression of RAGE mRNA | decreases expression | 16788091
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of RAGE mRNA | increases expression | 15336504
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of RAGE mRNA | increases expression | 20106945
|
D002117 |
Calcitriol |
Calcitriol results in increased expression of RAGE mRNA | increases expression | 16002434
|
D004317 |
Doxorubicin |
RAGE protein affects the susceptibility to Doxorubicin | affects response to substance | 16217747
|
D004958 |
Estradiol |
Estradiol results in increased expression of RAGE mRNA | increases expression | 15223131
|
D016685 |
Mitomycin |
RAGE protein affects the susceptibility to Mitomycin | affects response to substance | 16217747
|
D017239 |
Paclitaxel |
RAGE protein affects the susceptibility to Paclitaxel | affects response to substance | 16217747
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of RAGE mRNA | affects binding|decreases expression|increases activity | 19710929
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of RAGE mRNA | decreases expression | 17450228
|
D019772 |
Topotecan |
RAGE protein affects the susceptibility to Topotecan | affects response to substance | 16217747
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of RAGE mRNA | decreases expression | 16140955
|
D014747 |
Vinblastine |
RAGE protein affects the susceptibility to Vinblastine | affects response to substance | 16217747
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.20 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
4.56 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.56 | 11473722 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.60 | 16434500 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.83 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
5.04 | 16712894 17306315 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.64 | 21441931 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.68 | 15955085 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.12 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.28 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.36 | 16456186 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.50 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.25 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
9.25 | 16206674 16197459 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.83 | 14601052 |
MESH:D001859 |
Bone Neoplasms |
|
Paclitaxel |
4.65 | 15867366 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.88 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
2.38 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.38 | 18234424 15567936 16096432 15993339 18695136 16115903 16264153 15136595 18628466 17369602 19526202 17983394 16322301 15939500 16595493 18382427 16826403 15668708 15692762 17426702 16935488 11325840 15994142 15634643 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.38 | 17289903 16675129 17018787 18497071 17261762 14630087 19861407 12948864 |
MESH:D001943 |
Breast Neoplasms |
|
Paclitaxel |
2.38 | 18323546 16115903 16273361 18234424 16244791 11325840 15136595 18223236 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.38 | 16873071 16166294 16443354 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.71 | 16813970 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.58 | 16111702 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
4.94 | 16051944 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.29 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
9.03 | 18059187 16234567 17876044 16023760 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
9.03 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Paclitaxel |
9.03 | 16313753 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
9.03 | 16507464 17306315 15276417 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
9.03 | 1917145 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
7.07 | 16201981 1485588 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Vinblastine |
7.07 | 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
11.02 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
11.02 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
11.02 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
11.02 | 16096774 16051514 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.58 | 15476868 17974986 17519947 16269455 16364871 17007740 16455267 15792986 17329180 16612575 17131338 16952015 16731534 17924179 16242529 17382496 16651473 16278810 17308081 15505089 16109756 18627295 15811867 17351982 17928571 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.97 | 16243910 17334414 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.14 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
11.50 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
11.50 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
11.50 | 20056578 19524636 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.71 | 16129372 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.96 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.96 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.29 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.70 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.81 | 17035595 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
3.70 | 18802399 18259882 |
MESH:D015179 |
Colorectal Neoplasms |
|
Paclitaxel |
3.70 | 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Vinblastine |
3.70 | 18802399 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
1.82 | 16925845 14991402 9142499 9664655 9211117 10589399 9224671 17551590 8800419 9125849 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.46 | 18249437 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.48 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
2.46 | 17416283 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
3.73 | 18602426 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.56 | 12083418 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
4.60 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
4.03 | 15138306 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
12.79 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
12.79 | 11473722 18566989 19148513 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
12.79 | 16569247 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.29 | 18037988 |
MESH:D004938 |
Esophageal Neoplasms |
|
Paclitaxel |
2.91 | 16481741 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.64 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
7.83 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
7.83 | 19236843 20131406 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.70 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
9.04 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
9.04 | 17994277 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.80 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.34 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
7.41 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
7.41 | 17312396 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
8.02 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
8.02 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.29 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
2.93 | 9664655 14991402 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.54 | 16244371 12587719 14766674 16707910 18674790 16330681 16879835 16495754 17875725 16144979 17888722 16244372 18006777 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
7.21 | 17481944 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
7.21 | 20558911 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.98 | 15692506 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.54 | 15720958 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.10 | 16221962 19772884 18467677 19176532 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.17 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
12.82 | 15147373 18501091 17606976 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
12.82 | 12676792 |
MESH:D006689 |
Hodgkin Disease |
|
Vinblastine |
12.82 | 18180244 18501091 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.89 | 17088409 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.28 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.67 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.26 | 20558911 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.12 | 10903974 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
3.04 | 12646999 15346721 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
7.37 | 16627594 16393666 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.37 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.87 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
3.98 | 15992940 17551590 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.58 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
14.83 | 8314463 18776723 10903974 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
14.83 | 15369732 16775033 15699352 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
14.83 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
14.83 | 20008137 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.23 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.50 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
7.50 | 15610895 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.81 | 17143497 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.29 | 16085563 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.78 | 16932348 19285840 16482212 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.09 | 16294345 19850784 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.20 | 17294898 17107899 16766008 16788101 15748426 17339181 12679006 19642359 16331271 9834237 17506722 19075265 17301526 19035177 17217047 17712046 17368321 16823087 17649720 19029980 16891316 17361223 16935935 19225113 16140955 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.36 | 9224671 |
MESH:D008080 |
Liposarcoma |
|
Paclitaxel |
4.91 | 17353645 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
5.04 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
5.04 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
5.04 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
5.04 | 16248980 18397230 |
MESH:D008113 |
Liver Neoplasms |
|
Mitomycin |
7.73 | 15113037 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
7.73 | 20007298 16377806 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
7.73 | 16712894 15276417 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
3.06 | 16842330 17085340 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.22 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
2.66 | 17418594 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
2.66 | 17306315 16712894 15276417 19931552 17077188 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.52 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
9.19 | 17654614 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Paclitaxel |
9.19 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.67 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
6.29 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
6.29 | 17203775 11408345 11807958 16891317 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.62 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.81 | 17453147 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
9.98 | 16827129 |
MESH:D008545 |
Melanoma |
|
Paclitaxel |
9.98 | 16342250 12040289 12025231 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
9.98 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
9.98 | 16752155 |
MESH:D008545 |
Melanoma |
|
Vinblastine |
9.98 | 15577323 16432458 16248763 16809738 17761969 15577320 18332650 18505091 12374674 18176117 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.53 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.09 | 17638057 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.92 | 16801185 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.58 | 15792986 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.91 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
Paclitaxel |
3.74 | 14749477 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.61 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.12 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
5.81 | 15857846 19429709 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.81 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
8.46 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
8.46 | 16411023 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
6.23 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Paclitaxel |
6.23 | 15867366 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
8.46 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
8.46 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
8.46 | 16594593 16946489 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.77 | 20056578 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.85 | 17289903 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.87 | 16899518 16636307 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.58 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
9.54 | 19348381 18481113 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
9.54 | 16889571 15640375 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
9.99 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
9.99 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
7.48 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
7.48 | 9142499 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
7.42 | 15555623 |
MESH:D009447 |
Neuroblastoma |
|
Topotecan |
7.42 | 15176712 |
MESH:D009503 |
Neutropenia |
|
Vinblastine |
4.66 | 17378895 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.83 | 20558911 |
MESH:D010014 |
Osteolysis |
|
Paclitaxel |
5.10 | 15867366 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.18 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
11.52 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Paclitaxel |
11.52 | 11161223 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
11.52 | 15276417 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
11.52 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.97 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Mitomycin |
5.72 | 15113037 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
5.72 | 15976015 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.29 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.29 | 17638057 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.29 | 12371664 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.90 | 15572423 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.97 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
1.88 | 16289102 18247401 12479363 15754350 16644109 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
1.88 | 16888761 15897917 15749863 18437689 16868541 16729912 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
1.88 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Paclitaxel |
1.88 | 17172428 17136230 16356831 16729912 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
1.88 | 16039940 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.69 | 16636307 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.25 | 16882103 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.91 | 16723453 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.33 | 17922066 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.42 | 19058328 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.19 | 16283617 16116481 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.06 | 17203757 15625365 15675481 17710206 18313854 16767912 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.34 | 16326096 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.91 | 17846226 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
13.91 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
13.91 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
13.91 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
13.91 | 16467112 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.67 | 16767912 17203757 15625365 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.86 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Paclitaxel |
2.69 | 18396642 18506536 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.69 | 17261132 |
MESH:D024801 |
Tauopathies |
|
Paclitaxel |
4.93 | 16930453 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
7.52 | 17909728 16010429 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
7.52 | 17045167 16026305 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.82 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.86 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.27 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
5.36 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
5.36 | 17306315 11723127 16452187 16712894 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
9.67 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
9.67 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.74 | 16752155 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.12 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Vinblastine |
5.15 | 15577323 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.54 | 17056641 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.33 | 17678736 17638931 17334414 16364871 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.15 | 16761959 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.04 | 16287080 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.58 | 17120751 |